Structural and analytical reference
Understand why HPLC purity, peptide identity, sterility and endotoxin results are separate attributes when reviewing a research-material COA.
A high HPLC purity percentage is not a sterility result. Chromatography, identity testing, microbiological testing and endotoxin testing answer different questions and need separate evidence.
Map the claim to the test
| Attribute | What the evidence addresses | What it does not establish by itself |
|---|---|---|
| HPLC area purity | Relative chromatographic peak area under a specified method | Sterility, endotoxin level or net peptide mass |
| Mass-spectrometric identity | Consistency of a mass assignment with a declared structure | Every impurity or microbiological attribute |
| Sterility testing | Microbial growth under the stated test conditions | Absence of endotoxin or every contaminant |
| Bacterial endotoxin testing | Endotoxin response under a suitable method | Sterility or peptide sequence identity |
| Net peptide content | Quantitative peptide amount on a declared basis | A complete microbiological quality profile |
A test panel should be read attribute by attribute. One favorable result cannot fill blank fields elsewhere in the report.
Why microbiological and chemical results differ
A chromatographic detector measures a particular analytical response from material separated by the method. It is not a microbial growth test. Likewise, a mass assignment can support chemical identity without determining whether the preparation meets a microbiological specification.
Endotoxin is a separate concern from viable microbial growth. A material can require an endotoxin evaluation even when a microbial test is also performed. The result must include a suitable method, units and the relevant detection or reporting limit.
Read the sample and scope
Identify what was tested: bulk peptide, a filled vial, a water preparation or a final solution. A result for one stage should not be transferred silently to another. Sample preparation and method suitability matter, especially when the material can affect the test response.
FDA references discuss testing frameworks for regulated products. They are useful for understanding why attributes are separated, but citing a guidance document does not make a research material approved, sterile or suitable for administration.
A practical COA review
- Find the exact sample label and lot designation.
- List each reported test, method, result, units and acceptance criterion.
- Record missing attributes as “not reported” rather than guessing a pass.
- Check whether the report describes method suitability or limitations.
- Separate a supplier-published report from independent verification and current fulfillment information.
For example, a report showing HPLC and MS but no sterility or endotoxin entry supports review of the reported chemical tests. It does not support adding “sterile” or “endotoxin-free” to the material description. This rule applies equally to a powder, blend or separately supplied laboratory water.
Frequently asked questions
Does 99% HPLC purity mean sterile?
No. It is a chromatographic result under a specified method, not a sterility test.
Does a sterility result mean endotoxin-free?
No. Endotoxin requires its own suitable testing and result interpretation.
Can a clean-looking vial establish these attributes?
Appearance does not substitute for the corresponding analytical or microbiological evidence.
Continue learning
Sources and scope
- FDA, Pyrogen and Endotoxins Testing: Questions and Answers. Regulated-product testing reference. Its inclusion does not establish drug status or approval for research materials.
- FDA, Biotechnology Inspection Guide. Distinguishes analytical characterization, microbial controls and endotoxin.
- FDA, ICH Q6A specifications framework. Regulated-product reference with separate test attributes; not an SRL product certification.
This original SRL reference uses the linked scientific and labeling records for molecular or analytical context. It does not reproduce an experimental protocol or certify a supplier batch. Prepared October 2, 2026.
